Equally, our group and others have demonstrated that PP2A activity is reduced in IPF, and chemical activation of PP2A can reduce bleomycin-induced fibrosis in mice [9,110,111]. This evidence concerns the gene PTPA and idiopathic pulmonary fibrosis.